FDA investigating safety risks in CAR T-cell recipients

被引:14
|
作者
Nelson, Roxanne
机构
来源
LANCET | 2023年 / 402卷 / 10418期
关键词
D O I
10.1016/S0140-6736(23)02747-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2181 / 2181
页数:1
相关论文
共 50 条
  • [21] RNA Therapeutics for Improving CAR T-cell Safety and Efficacy
    Schaible, Philipp
    Bethge, Wolfgang
    Lengerke, Claudia
    Haraszti, Reka Agnes
    CANCER RESEARCH, 2023, 83 (03) : 354 - 362
  • [22] T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)
    Di Napoli, Raffaella
    Balzano, Nunzia
    Ruggiero, Rosanna
    Mascolo, Annamaria
    Scavone, Cristina
    di Mauro, Gabriella
    Capuano, Annalisa
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [23] T-Cell Cancer after CAR T-Cell Therapy
    Mitchell, Emily
    Vassiliou, George S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (22): : 2120 - 2121
  • [24] The CAR T-Cell Race
    Brower, Vicki
    SCIENTIST, 2015, 29 (04): : 81 - 84
  • [25] CAR T-CELL IMMUNOTHERAPY
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 8 - 9
  • [26] CAR T-cell therapy
    Cookson, Emma
    LANCET HAEMATOLOGY, 2022, 9 (05): : E322 - E322
  • [27] A tunable safety switch for solid tumor CAR T-cell therapy
    Misawa, Kyohei
    Taleb, Meriem
    Banerjee, Srijita
    Vista, William-Ray
    Chintala, Navin K.
    Adusumilli, Prasad S.
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Fasten the seat belt: Increasing safety of CAR T-cell therapy
    Simon, Bianca
    Uslu, Ugur
    EXPERIMENTAL DERMATOLOGY, 2020, 29 (11) : 1039 - 1045
  • [29] Tecartus First CAR T-Cell Therapy FDA Approved for Patients with Mantle-Cell Lymphoma
    Marks, Peter
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (05): : 215 - 215
  • [30] Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients
    Johnson, P. Connor
    Dhawale, Tejaswini
    Newcomb, Richard A.
    Barata, Ana
    Karpinski, Kyle
    Lavoie, Mitchell W.
    Vaughn, Dagny
    Hennessey, Kathleen
    Schneider, David
    Amonoo, Hermioni L.
    Volandes, Angelo
    El-Jawahri, Areej
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (02):